Company intelligence / Profile preview

NeuroVista

Seattle, Washington, United Statesneurovista.org ↗

Ownership: Private
Development stage: Preclinical

Overview

NeuroVista developed an implantable device that could predict epileptic seizures by monitoring intracranial EEG signals. In a first-in-human study with 11 patients with drug-resistant epilepsy, the system demonstrated feasibility in predicting seizure likelihood. However, the original company is no longer active and did not reach commercialization. Newer companies using similar names focus on non-invasive BCI or AI-powered diagnostics but are unrelated to the original entity.

Therapeutic areas: Neurology
Modalities: DeviceDigital health platform
Industry: Implantable Medical Devices

Partnerships

Advanced Technology VenturesDelphi VenturesThree Arch PartnersSprout GroupFoundation Medical Partners

Beyond the preview

Go deeper on NeuroVista.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroVista.

Explore the full profile